RWJ-26240

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NameRWJ-26240

Drug Alias NameRWJ-26240

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionVoltage-gated calcium channel blockers

TargetsVoltage-gated calcium channel

Therapy Area/IndicationsHypertension

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesJohnson & Johnson

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesJohnson & Johnson

Active IndicationsN/A

Inactive IndicationsHypertension

ATC CodeN/A